ZIG
IMGN

Zullo Investment Group’s Immunogen Inc IMGN Stock Holding History

Zullo Investment Group’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-152
Closed -$1K – 800
2022
Q2 		$1K Hold
152
– – ﹤0.01% 770
2022
Q1 		$1K Hold
152
– – ﹤0.01% 786
2021
Q4 		$1K Buy
+152
New +$945 ﹤0.01% 804

Other funds holding IMGN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Zullo Investment Group's IMGN Position: Q3 2022 in Review

Zullo Investment Group sold out of Immunogen Inc (IMGN) in Q3 2022, closing a stake of 152 shares — an estimated $1K sold.

Zullo Investment Group first reported a position in IMGN in Q4 2021 and held it in 3 quarters. The position peaked at $1K in Q2 2022. 222 funds tracked by Wall St. Rank hold IMGN as of Q3 2022.

  • Zullo Investment Group reported no remaining Immunogen Inc position as of Q3 2022 after selling out during the quarter.
  • Zullo Investment Group sold 152 Immunogen Inc shares in Q3 2022, an estimated $1K.
  • Zullo Investment Group first reported a position in Immunogen Inc in Q4 2021 and held it in 3 quarters.
  • Zullo Investment Group's Immunogen Inc position peaked at $1K in Q2 2022.
  • 222 funds tracked by Wall St. Rank held Immunogen Inc as of Q3 2022.

Based on Zullo Investment Group's 13F filing for Q3 2022, filed 8 Nov 2022.